Khalifa University today announced its collaboration partner, Creo Medical Group of the UK, which earlier this year established its local presence in Abu Dhabi with joint research laboratories at the University, has won the King’s Award for Enterprise in Innovation, an accolade that honours innovative UK companies for their impact in their respective sectors.
The prestigious award was presented to Craig Gulliford, Chief Executive Officer, Creo Medical, during a ceremony at Windsor Castle. Creo is a medical device company focused on innovation in minimally invasive surgical endoscopic technologies, developing Advanced Energy platforms and devices that utilise microwave and radiofrequency energy for cutting, coagulating, and ablating soft tissue during endoscopic surgical procedures (surgery performed without making incisions through the skin). Creo’s devices allow doctors to remove cancerous and pre-cancerous growths and complex lesions from inside the body, including in the bowel, oesophagus, and lung.
The
award recognises the company’s outstanding achievements in providing transformational improvements in cancer patient treatment and outcomes while at the same time, by way of simplified procedures and reduced time in hospital, providing substantial operational improvements and reduction in costs in the healthcare system.
Craig Gulliford Creo Medical Chief Executive said, ‘We are delighted to have received this award from His Majesty The King in recognition of our team’s outstanding work, dedication and achievements towards innovation in healthcare across the globe. Khalifa University played an instrumental role in attracting us to establish a local presence in Abu Dhabi to serve the UAE, Middle East and wider Africa region. Its commitment to advancing engineering and technology research, innovation and enterprise to improve medical science and practice makes the University an ideal partner, with the attendant proximity to talent and discovery enabling us further to develop our technology and activities locall
y.’
Khalifa University President Sir John O’Reilly said, ‘The award for Creo Medical bears testimony to the extent of Khalifa University’s collaboration with globally leading innovation pioneers across all areas including medical sciences, as well as commercialisation and application, patient care and diagnostics. We strongly believe our research expertise combined with technological breakthrough medical technology solutions from Creo will usher in an era that will benefit not only the region but the global community as well.’
Khalifa University’s partnership with Creo is structured around three main areas – research, education and investments. As well as engaging with university faculty in research and innovation such as Advanced Energy electrosurgical sensing and advancing Creo’s Plasma Technology for sterilisation and advanced wound care. The company contributes to the educational mission, including fostering innovation in technology and entrepreneurship with presentations such as ‘Anyone Can Be an Entre
preneur’ with Creo Medical’s journey providing an insightful, inspiring, practical case study for students.
Source: Emirates News Agency